Phase 2 Readout
TRVI: Phase 2 Readout: haduvio
December 31, 2026 · haduvio. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Trevi Therapeutics, Inc. (TRVI)
- Drug
- haduvio
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: haduvio
- Drug
- haduvio
- Indication
- chronic cough in patients with non-IPF interstitial lung disease